Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_assertion type Assertion NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_head.
- NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_assertion description "[To know the association of ALDH2/AHD2 polymorphism with diabetic vasculopathy and neuropathy, a total of 158 patients with type 2 diabetes were divided into four groups on the basis of ALDH2 `activity` and ADH2 `superactivity.` The frequency of proteinuria and the percentage of proliferative retinopathy among the patients with retinopathy was higher in those with active ALDH2 and superactive ADH2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_provenance.
- NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_assertion evidence source_evidence_literature NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_provenance.
- NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_assertion SIO_000772 15318096 NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_provenance.
- NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_assertion wasDerivedFrom befree-20140225 NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_provenance.
- NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_assertion wasGeneratedBy ECO_0000203 NP203602.RAiYwusuzaiwZXXAz-avHXlgAzYCPTtLAHEP-mWgJlN5I130_provenance.